期 |
栏目 |
标题 |
文件 |
卷 30, 编号 5 (2019) |
Articles |
The pathogenesis of atrophic gastritis: immunological aspects |
|
卷 30, 编号 6 (2019) |
Articles |
The frequency and clinical aspects of Barrett’s esophagus in elderly patients |
|
卷 30, 编号 11 (2019) |
Articles |
Lipid peroxidation and antioxidant defense in chronic atrophic gastritis associated with Helicobacter pylori |
|
卷 30, 编号 12 (2019) |
Articles |
Current principles of management in patients with opisthorchiasis |
|
卷 31, 编号 6 (2020) |
Articles |
What conclusions should be drawn from the association between liver diseases and cholelithiasis? |
|
卷 31, 编号 5 (2020) |
Articles |
The indices of gastric mucosal epithelial cell proliferation and apoptosis in Helicobacter pylori-positive duodenal ulcer in the native inhabitants of the Republic of Tuva |
|
卷 24, 编号 10 (2013) |
Articles |
ASSOCIATION OF INFECTIOUS FACTORS WITH BILIARY TRACT DISEASES |
|
卷 24, 编号 10 (2013) |
Articles |
SIMULATION OF GASTROESOPHAGEAL REFLUX DISEASE IN OLD AGE GROUPS |
|
卷 25, 编号 3 (2014) |
Articles |
EXTRAESOPHAGEAL MANIFESTATIONS AND THEIR EARLY SYMPTOMATIC THERAPY IN ELDERLY PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE |
|
卷 25, 编号 1 (2014) |
Articles |
PROGRESSIVE GASTROESOPHAGEAL REFLUX DISEASE IN ELDERLY PEOPLE AND RISK FACTORS |
|
卷 25, 编号 1 (2014) |
Articles |
SPECTRUM BILE ACIDS IN BILE AND SERUM LIPIDS IN PATIENTS WITH CHOLELITHIASIS AMONG NATIVE AND ALIENS INHABITANTS OF EVENKIA |
|
卷 27, 编号 2 (2016) |
Articles |
EARLY SYMPTOMATIC THERAPY WITH ALGINATES AND ANTACIDS IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE |
|
卷 27, 编号 7 (2016) |
Articles |
THE ABILITIES OF A BISMUTH PREPARATION IN GASTROINTESTINAL DISEASES |
|
卷 27, 编号 10 (2016) |
Articles |
PREVENTION OF CHOLELITHIASIS |
|
卷 28, 编号 1 (2017) |
Articles |
POSSIBILITIES OF USING PROBIOTICS FOR HELICOBACTER PYLORI ERADICATION: MAASTRICHT V CONSENSUS CONFERENCE RECOMMENDATIONS |
|
卷 29, 编号 10 (2018) |
Articles |
Diagnosis, prevalence, and risk factors of atrophic gastritis |
|
卷 29, 编号 12 (2018) |
Articles |
The prevalence and risk factors of peptic ulcer disease |
|